DRUG · COUNSELLING NOTES
Ocrelizumab
OCREVUS
Updated
New prescription
indication: _____. IV q6mo, premedicated, observed after; no live vaccines; warned on allergies; serious/common AEs: infusion reactions, infections, PML; non-pharm: exercise, energy conservation.
Refill prescription
refilled, adherence discussed, no SEs were reported
Dose change
Dose change discussed. new dose reviewed; IV q6mo, premedicated, observed after; no live vaccines; warned on allergies; serious/common AEs: infusion reactions, infections, PML; non-pharm: exercise, energy conservation.